Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
MyCural Therapeutics AB
AB
Active
Org 5593950164
Sidenvävargatan 17, 753 19
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 3 years old
10-19 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
MyCural Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2023: 0M
0M
2023
2024: 1M
1M
2024
EBITDA
SEK millions
0M
-2M
-5M
-7M
-10M
2023: -6M
-6M
2023
2024: -8M (-33% vs 2023)
-8M
-33%
2024
Income statement
SEK thousands
Item
2024
2023
Revenue
799
25
Staff expenses
—
—
EBITDA
−7 703
−5 907
Depreciation & amort.
−0
−0
EBIT
−7 703
−5 907
Net financials
73
46
Profit before tax
−7 630
−5 862
Tax
−0
−0
Net profit
−7 630
−5 862
Balance sheet
SEK thousands
Item
2024
2023
Total assets
5 799
5 815
Equity
4 240
4 598
Long-term debt
0
0
Short-term debt
1 559
1 217
Total debt
1 559
1 217
Financial ratios
5-year trend
EBITDA margin
−964,1 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2023
2024
Equity ratio
73,1 %
This company
38,2 %
Market median
This company
Market median
91% above market
2023
2024
Return on equity
−180,0 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2023
2024
Net profit margin
−954,9 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2023
2024
Asset turnover
0,14×
This company
1,12×
Market median
This company
Market median
88% below market
2023
2024
Debt / equity
0,37×
This company
0,62×
Market median
This company
Market median
40% below market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-12-31
View
PDF
More on MyCural Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
